Partnering in Medtech: Perspectives from Québec and Massachusetts
Wednesday, January 31, 2024 (12:00 PM - 1:00 PM) (EST)
A rapidly changing technological landscape and a globalized marketplace have increased competition and the pressure to innovate for Massachusetts’ Medtech companies. Seeking international partnerships is an important way for companies to both expand their global presence and benefit from a wider pool of innovations. Massachusetts and Québec are two of the strongest Medtech ecosystems today.
This webinar will highlight examples of partnerships between leading Medtech companies from Québec, Massachusetts and elsewhere in the US. Participants will learn key takeaways, such as:
- Trends in the Medtech partnership space and why they are increasingly critical to success in today’s market
- Challenges and lessons learned from companies with years of partnership experience in the US
- The advantages and disadvantages of different types of partnerships
- Information about the strength of the Québec Medtech cluster, and how the government and industry have collaborated to foster it
|Geneviève Lavertu, LLB, BCL, MSc
Director, Government Affairs and Policy
Johnson & Johnson Medical Technology
Geneviève Lavertu is a senior executive in the health technologies sector, who prior to joining J&J MedTech was a consultant with life sciences companies, advising on their commercialization strategy. She was previously with Medtronic Canada in senior roles on its leadership team, including Senior Director of Medtronic Care Management Services, and head of Legal, Scientific Affairs and Business Development. Before then, Geneviève was general counsel and corporate secretary of ProMetic Life Sciences Inc. (now Liminal BioSciences Inc.), after practicing law with Stikeman Elliott LLP in mergers and acquisitions, competition and commercial law in the information technology and life sciences industries.
Ms. Lavertu is a member of the C.D. Howe Institute’s Health Policy Council, founding Board member of MEDTEQ+ and Chair of its Investment Committee. She chairs the Research Oversight Committee of two medical technology R&D projects ($27.8M over 3 years) overseen by the CQDM life sciences research consortium. She has also served on the Advisory Board of the Medical Device Research Centre of the National Research Council of Canada (NRC).
Ms. Lavertu is a lawyer in Ontario and Quebec, a MSc graduate in Political Economy from London School of Economics and Political Science (London, UK) and a graduate of France’s École Nationale d’Administration (ENA), now the National Institute of Public Service (INSP).
Director, Business Development
OpSens Medical, a Haemonetics Company
Ryan Rinehart is an expert in medical device design and commercialization, specifically in the areas of business development, sales, operations, and manufacturing engineering. He has experience in the contract development and manufacturing markets through his time at Philips-Medisize (Molex) and Minnetronix Medical, as well as interventional cardiology through his current role as Director, Business Development at OpSens Medical, a cardiology-focused medical device company delivering innovative solutions based on its proprietary optical sensing technology, where he is responsible for the OEM Solutions business unit.
He recently was a part in the acquisition of OpSens Medical by Haemonetics, a medical device company focused primarily on blood and plasma component collection, the surgical suite, and hospital transfusion services, but has recently acquired Cardiva and OpSens as it enters and plans to innovate in the cardiology space.
Vice President, Robotics & Digital Surgery Cambridge Consultants
As the leader of robotic and digital surgery technology at Cambridge Consultants, Alex guides teams in developing groundbreaking products to shape the future of healthcare. His work is focused on identifying high value opportunities for clients and creating novel solutions for an increasingly digital future. Alex specializes in realizing winning competitive strategies in highly uncertain environments through a systematic approach to innovation. His technical experience ranges from computer vision algorithms and novel robotic manipulators to connected digital platforms.
Vice President, Strategic Growth
For the past decade, François has been instrumental in leading Kinova from a small startup to international success.
The versatile leader’s main focus is business growth, but the hats he’s worn since joining Kinova include product development, marketing, strategy, talent, and culture. It’s his ability to work with teams and fearlessness in taking on new challenges that quickly propelled him to become Kinova’s VP of Strategic Growth.
François graduated from Université Laval in 2002, completing his bachelor’s degree in physics engineering and he immediately followed this up by earning his master’s in business management
His formative years allowed him the opportunity to build a strong technical knowledge on subjects he was passionate about, while also developing his business acumen and leadership abilities. Today, his main role with Kinova is to lead corporate expansion in medical robotics.